Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis

Presse Medicale

Volumn 40, Issue 4, 2011, Pages

  Gherardi, Romain K ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD20 ANTIGEN; CD68 ANTIGEN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RO ANTIBODY; SYNTHETASE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TRANSFER RNA;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; DERMATOMYOSITIS; ENDOPLASMIC RETICULUM; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROVASCULARIZATION; MUSCLE CAPILLARY; MUSCLE CELL; MYOSITIS; NECROTIZING MYOPATHY; PATHOPHYSIOLOGY; POLYMYOSITIS; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UPREGULATION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CAPILLARIES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT MEMBRANE ATTACK COMPLEX; DERMATOMYOSITIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; IMMUNITY, INNATE; MITRAL VALVE PROLAPSE; MUSCLES; MYOFIBRILS; MYOPIA; MYOSITIS, INCLUSION BODY; PHENOTYPE; POLYMYOSITIS; SKIN DISEASES;

EID: 79953769227     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.12.013     Document Type: Short Survey

References (87)

1. Sultan S.M., Isenberg D.A. Re-classifying myositis: 30 years on from Bohan and Peter. Rheumatology 2010, 49:831-833.
2. Askanas V., Engel W.K. Sporadic inclusion-body myositis: conformational multifactorial aging-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau. Presse Med 2011, 40:e219-e235.
3. Authier F.J. Myopathies inflammatoires et dysimmunitaires. Rev Prat 2008, 58:2253-2260.
4. Dimitri D. Myopathies inflammatoires: diagnostic et classifications. Presse Med 2009, 38:1141-1163.
5. Dalakas M.C. Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362:971-982.
6. Bassez G., Authier F.J., Lechapt-Zalcman E., Illa I., Gherardi R.K. Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis. J Neuropathol Exp Neurol 2003, 62:464-474.
7. Grundtman C., Lundberg I.E. Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies. Autoimmunity 2009, 42:615-626.
8. Engelson E.T., Skalak T.C., Schmid-Schonbein G.W. The microvasculature in skeletal muscle. I. Arteriolar network in rat spinotrapezius muscle. Microvasc Res 1985, 30:29-44.
9. Snyder G.K. Anatomical organisation of the microvasculature in the anterior and posterior latissimus dorsi muscles of the chicken. J Anat 1988, 156:97-106.
10. Schmid-Schonbein G.W., Skalak T.C., Firestone G. The microvasculature in skeletal muscle. V. The microvascular arcades in normotensive and hypertensive rats. Microvasc Res 1987, 34:385-393.
11. Bloch E.H., Iberall A.S. Towards a concept of the functional unit of mammalian skeletal muscle. Am J Physiol 1982, 242:R411-R420.
12. Lund N., Damon D.H., Damon D.N., Duling B.R. Capillary grouping in hamster tibials anterior muscles: flow patterns, and physiological significance. Int J Microcirc Clin Exp 1987, 5:359-372.
13. Chen M., Daha M.R., Kallenberg C.G.M. The complement system in systemic autoimmune disease J. Autoimmunity 2010, 34:J276-J286.
14. Greenberg S.A., Amato A.A. Uncertainties in the pathogenesis of adult dermatomyositis. Curr Opin Neurol 2004, 17:359-364.
15. Christov C., Chrétien F., Abou-Khalil R., Bassez G., Vallet G., Authier F.J., et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 2007, 18:1397-1409.
16. Price R.J., Skalak T.C. Arteriolar remodeling in skeletal muscle of rats exposed to chronic hypoxia. J Vasc Res 1998, 35:238-244.
17. Reffelmann T., Kloner R.A. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 2002, 87:162-168.
18. Almsherqi Z.A., Kohlwein S.D., Deng Y. Cubic membranes: a legend beyond the Flatland of cell membrane organization. J Cell Biol 2006, 173:839-844.
19. Fleming S.D., Monestier M., Tsokos G.C. Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. J Immunol 2004, 173:4230-4235.
20. Weiser M.R., Williams J.P., Moore FDJr, Kobzik L., Ma M., Hechtman H.B., et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996, 183:2343-2348.
21. Zhang M., Alicot E.M., Chiu I., Li J., Verna N., Vorup-Jensen T., et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 2006, 203:141-152.
22. Stahl G.L., Xu Y., Hao L., Miller M., Buras J.A., Fung M., et al. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 2003, 162:449-455.
23. Collard C.D., Väkevä A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., et al. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 2000, 156:1549-1556.
24. Dimitri D., Andre C., Roucoules J., Hosseini H., Humbel R.L., Authier F.J. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology. Muscle Nerve 2007, 35:389-395.
25. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol 1986, 19:112-125.
26. Goebels N., Michaelis D., Engelhardt M., Huber S., Bender A., Pongratz D., et al. Differential expression of perforin in muscle-infiltrating T-cells in polymyositis and dermatomyositis. J Clin Invest 1996, 97:2905-2910.
27. Mantegazza R., Andreetta F., Bernasconi P., Baggi F., Oksenberg J.R., Simoncini O., et al. Analysis of T-cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. J Clin Invest 1993, 91:2880-2886.
28. O'Halon T.P., Dalakas M.C., Plotz P.H. Predominant TCR-aβ variable and joining gene expression by muscle infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 1994, 152:2569-2576.
29. Bender A., Behrens L., Engel A.G., Hohlfeld R. T-cell heterogeneity in muscle lesions of inclusion body myositis. J Neuroimmunol 1998, 84:86-91.
30. Benveniste O., Herson S., Salomon B., Dimitri D., Trebeden-Negre H., Jean L., et al. Long-term persistence of clonally expanded T-cells in patients with polymyositis. Ann Neurol 2004, 56:867-872.
31. Dimitri D., Benveniste O., Dubourg O., Maisonobe T., Eymard B., Amoura Z., et al. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Brain 2006, 129:986-995.
32. Salajegheh M., Rakocevic G., Raju R., Shatunov A., Goldfarb L.G., Dalakas M.C. T-cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis. Neurology 2007, 69:1672-1679.
33. Benveniste O., Cherin P., Maisonobe T., Merat R., Chosidow O., Mouthon L., et al. Severe perturbations of the blood T-cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001, 167:3521-3529.
34. Fasth A.E., Dastmalchi M., Rahbar A., Salomonsson S., Pandya J.M., Lindroos E., et al. T-cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T-cells. J Immunol 2009, 183:4792-4799.
35. Marino M., Scuderi F., Mazzarelli P., Mannella F., Provenzano C., Bartoccioni E. Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts. J Neuroimmunol. 2001, 116:94-101.
36. Kloetzel P.M., Ossendorp F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 2004, 16:76-81.
37. Mantegazza R., Gebbia M., Mora M., Barresi R., Bernasconi P., Baggi F., et al. Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: Implications for the immunopathogenesis of muscle autoimmune diseases. J Neuroimmunol 1996, 68:53-60.
38. Bernasconi P., Confalonieri P., Andreetta F., Baggi F., Cornelio F., Mantegazza R. The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: relevance for the pathogenesis of inflammatory myopathy. J Neuroimmunol. 1998, 85:52-58.
39. Behrens L., Kerschensteiner M., Misgeld T., Goebels N., Wekerle H., Hohlfeld R. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 1998, 161:5943-5951.
40. Wiendl H., Mitsdoerffer M., Schneider D., Melms A., Lochmuller H., Hohlfeld R., et al. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule. ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain 2003, 126:1026-1035.
41. Schmidt J., Rakocevic G., Raju R., Dalakas M.C. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8 T-cell cytotoxicity. Brain 2004, 127:1182-1190.
42. Sugiura T., Kawaguchi Y., Harigai M., Takagi K., Ohta S., Fukasawa C., et al. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production. J Immunol 2000, 164:6593-6600.
43. De Bleecker J.L., Engel A.G. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol 1994, 53:369-376.
44. Murata K., Dalakas M.C. Expression of the costimulatorey molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 1999, 155:453-460.
45. Wiendl H., Hohlfeld R., Kieseier B.C. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 2005, 26:373-380.
46. Wiendl H., Mitsdoerffer M., Schneider D., Chen L., Lochmüller H., Melms A., et al. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J 2003, 17:1892-1894.
47. Wiendl H., Behrens L., Maier S., Johnson M.A., Weiss E.H., Hohlfeld R. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann Neurol 2000, 48:679-684.
48. Calbo S., Delagreverie H., Arnoult C., Authier F.J., Tron F., Boyer O. Functional tolerance of CD8+ T-cells induced by muscle-specific antigen expression. J Immunol 2008, 181:408-417.
49. Waschbisch A., Schwab N., Ruck T., Stenner M.P., Wiendl H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol 2010, 225:137-142.
50. Allenbach Y., Solly S., Grégoire S., Dubourg O., Salomon B., Butler-Browne G., Musset L., et al. Role of regulatory T-cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 2009, 174:989-998.
51. Tidball J.G., Wehling-Henricks M. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis. Curr Opin Rheumatol 2005, 17:707-713.
52. Radley H.G., Grounds M.D. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiol Dis 2006, 23:387-397.
53. Brigitte M., Schilte C., Plonquet A., Baba-Amer Y., Henri A., Charlier C., et al. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum 2010, 62:268-279.
54. Chazaud B., Sonnet C., Lafuste P., Bassez G., Rimaniol A.C., Poron F., et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 2003, 163:1133-1143.
55. Tournadre A., Lenief V., Miossec P. Expression of toll-like receptor 3 and toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthtitis Rheum 2010, 62:2144-2151.
56. Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069.
57. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11:753-761.
58. Page G., Chevrel G., Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interactions with chemokines and Th1 cytokine-producing cells. Arthjritis Rheum 2004, 50:199-208.
59. Chevrel G., Page G., Granet C., Steichenberger N., Varennes A., Miossec P. Interleukin 17 increases the effect of IL-1 beta on muscle cells: arguments for a role of T-cells in the pathogenesis of myositis. J Neuroimmunol 2003, 137:125-133.
60. Tournadre A., Porcherot M., Chérin P., Marie I., Hachulla E., Miossec P. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins. Cytokine 2009, 46:297-301.
61. Tournadre A., Miossec P. Cytokine response in inflammatory myopathies. Clin Rheumatol Rep 2007, 9:286-290.
62. Lundberg I., Ulfgren A.K., Nyberg P., Andersson U., Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997, 40:865-874.
63. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007, 7:19-30.
64. Allenspach E.J., Lemos M.P., Porret P.M., Turka L.A., Laufer T.M. Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naïve CD4+ T-cells. Immunity 2008, 29:795-806.
65. Carbone F.R., Belz G.T., Heath W.R. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 2004, 25:655-658.
66. Wakim L.M., Waithman J., van Rooijen N., Heath W.R., Carbone F.R. Dendritic cell-induced memory T-cell activation in nonlymphoid tissues. Science 2008, 319:198-202.
67. Sapoznikov A., Fischer J.A., Zaft T., Krauthgamer R., Dzionek A., Jung S. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T-cells by plasmacytoid dendritic cells. J Exp Med 2007, 204:1923-1933.
68. Lundberg I.E., Helmers S.B. The type I interferon system in idiopathic inflammatory myopathies. Autoimmunity 2010, 43:239-243.
69. Isenberg D.A., Rowe D., Shearer M., Novick D., Beverley P.C. Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol 1986, 63:450-458.
70. Greenberg S.A., Sanoudou D., Haslett J.N., Kohane I.S., Kunkel L.M., BeggsAH, et al. Molecular profiles of inflammatory myopathies. Neurology 2002, 59:1170-1182.
71. Tezak Z., Hoffman E.P., Lutz J.L., Fedczyna T.O., Stephan D., Bremer E.G., et al. Gene expression profiling in DQA1*0501{thorn} children with untreated dermatomyositis: A novel model of pathogenesis. J Immunol 2002, 168:4154-4163.
72. Greenberg S.A., Pinkus J.L.M., Pinkus G.S., Burleson T., Sanoudou D., Tawil R., et al. Interferon alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005, 57:664-678.
73. Walsh R.J., Kong S.W., Yao Y., Jallal B., Kiener P.A., Pinkus J.L., et al. Type 1 interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 2007, 56:3784-3792.
74. Lopez de Padilla C.M., Vallejo A.N., McNallan K.T., Vehe R., Smith S.A., Dietz A.B., et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 2007, 56:1658-1668.
75. Eloranta M.L., Barbasso Helmers S., Ulfgren A.K., Ronnblom L., Alm G.V., Lundberg I.E. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum 2007, 56:3112-3124.
76. Krystufkova O., Vallerskog T., Barbasso Helmers S., Mann H., Putova I., Belacek J., et al. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 2009, 68:836-843.
77. Lundberg I.E., Grundtman C. Developments in the scientific and clinical understanding of inflammatory myopathies. Arthritis Res Ther 2008, 10:220.
78. Pavlath G.K. Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis. J Neuroimmunol 2002, 125:42-50.
79. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988, 23:64-72.
80. Nagaraju K., Casciola-Rosen L., Lundberg I., Rawat R., Cutting S., Thapliyal R., et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005, 52:1824-1835.
81. Vitadello M., Doria A., Tarricone E., Ghirardello A., Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther 2010, 12:R52.
82. Gunawardena H., Betteridge Z.E., McHugh N.J. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 2009, 48:607-612.
83. Labirua A., Lundberg I.E. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 2010, 22:633-638.
84. Suber T.L., Casciola-Rosen L., Rosen A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 2008, 4:201-209.
85. Casciola-Rosen L., Nagaraju K., Plotz P., Wang K., Levine S., Gabrielson E., et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005, 201:591-601.
86. Mammen A.L., Casciola-Rosen L.A., Hall J.C., Christopher-Stine L., Corse A.M., Rosen A. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum 2009, 60:3784-3793.
87. Rosen A., Casciola-Rosen L. Autoantigens in systemic autoimmunity: critical partner in pathogenesis. J Intern Med 2009, 265:625-631.